ONX 0805 | SB1578 | MedKoo Biosciences

Back to products

Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

MedKoo product information:

ONX 0805

MedKoo Code#: 205625
Name: ONX 0805
CAS#: Synonym: ONX 0805; SB1578 　 IUPAC/Chemical name:
Chemical structure	Theoretical analysis

Availability and price: This agent is not in stock, may be available through custom synthesis. To inquire quotation and lead time or to ask questions, please send email to sales@medkoo.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.

Information about this agent

SB1518 (ONX 0803) has been designed to suppress the overactivity of mutant JAK2 and is currently in multiple Phase 1 studies. Data from these Phase 1 dose-ranging studies, evaluating the compound in patients with primary myelofibrosis, are anticipated in the first half of 2009.

Current developer: S*Bio/Onxy Pharmaceuticals.

References

Contact MedKoo:

Email: sales@medkoo.com

(Keyword; CAS#; MedKoo code#)